Cooley Advises Jazz Pharmaceuticals in Acquisition of ADX-N05

Palo Alto, Calif. – January 23, 2014 – Cooley LLP announced today that it represented Jazz Pharmaceuticals plc in its $125 million acquisition of the worldwide development, manufacturing and commercial rights to ADX-N05 from Aerial BioPharma, LLC. ADX-N05 is being developed for the treatment of excessive daytime sleepiness in patients suffering from narcolepsy.

The Cooley team representing Jazz included partner Marya Postner and associates Bin Wang and Holly Holloway (life sciences); partner Chadwick Mills (capital markets); partners Bill Morrow and Mark Windfeld-Hansen (tax); partners Mischi a Marca and Michael Tollini and associates Amanda Fant and Jason Savich (credit finance); partner Francis Fryscak (antitrust); partner Natasha Leskovsek (health care & life sciences regulatory); and partner Gregory Tenhoff and associate Tyler Onitsuka (employment).

View the company press release here.

About Cooley LLP

Cooley's attorneys solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters and bet-the-company litigation, often where innovation meets the law.

Cooley has more than 750 lawyers across 11 offices in the United States and China.

Related Contacts
Bill Morrow Retired Partner, San Diego
Gregory Tenhoff Partner, Palo Alto
Marya Postner Partner, Palo Alto
Mischi a Marca Partner, San Francisco
Chadwick Mills Partner, San Francisco
Bin Wang Associate, Beijing
Jason Savich Partner, San Francisco
Michael Tollini Partner, Washington, DC
Natasha Leskovsek Partner, Washington, DC
Mark Windfeld-Hansen Partner, Palo Alto
Amanda Fant Associate, San Francisco